DoW Alzheimer's Transforming Diagnosis Award
This grant funds innovative research to improve Alzheimer's diagnosis, monitoring, and prognosis, requiring preliminary data and community collaboration, but prohibits clinical trials and animal studies.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 22, 2026: Pre-Application (Preproposal) | September 24, 2026: Full Application | September 29, 2026: Application Verification Period Ends
Funding Amounts: ~$3.2M total; up to $1.5M per award (single PI) or $1.7M combined (CIT Partnership); max 4 years
Summary: Supports non-incremental, solutions-oriented research to overcome barriers in Alzheimer’s diagnosis, monitoring, and prognosis; clinical trials and animal research are prohibited.
Key Information: Preliminary data and community collaboration (for human subject studies) are required; eligibility is broad but excludes mentored positions.
Description
This opportunity funds research through the Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA), aiming to reduce or overcome significant barriers in obtaining a diagnosis, monitoring disease progression, and providing accurate prognosis for Alzheimer’s disease and related dementias (AD/ADRD). The program seeks impactful, solutions-oriented projects that address unmet clinical needs. Clinical research is permitted, but clinical trials and animal studies are not. Projects must be grounded in preliminary data, and collaboration with community stakeholders is required for studies with prospective human enrollment.
The TrDA mechanism encourages the use of existing cohorts or datasets and welcomes research involving individuals 65 years or younger. The Career Initiation or Transition (CIT) Partnership Option allows for collaborative applications, supporting both new and established partnerships, with specific eligibility requirements for participating investigators.
